The invention discloses a blood-pressure-reducing anticancer tea. The blood-pressure-reducing anticancer tea is prepared from siberian solomonseal rhizome, ganoderma sinense, cordyceps sinensis, codonopsis pilosula, dry herba gynostemmatis (prepared), radix notoginseng (prepared), siberian solomonseal rhizome (prepared), puerariae thomsonii (prepared), and polygonatum odorati (prepared). The materials are uniformly mixed and stirred, and are crushed into a fine powder. The powder is sieved by a sieve with 80 to 100 meshes, and the refined powder is packed. The invention is advantaged in that:the blood-pressure-reducing anticancer tea is formulated with purposes of blood pressure reducing, blood fat reducing, blood sugar reducing, thrombolysing, cancer preventing, cancer resisting, and aging retarding. The blood-pressure-reducing anticancer tea provides efficacies of blood vessel dredging, hrombolysing, blood sugar reducing, qi and blood regulating, marrow strengthening, detoxifying, hard mass softening and resolving, and self-immunity improving. The blood-pressure-reducing anticancer tea has substantial curative effects against hypertension, hyperlipemia, hyperglycemia, and diabetes mellitus, and has cancer preventing and cancer resisting effects. The tea has important significance in disease preventing, life quality improving, and aging retarding. The tea has no toxic or side-effect upon human bodies, and is safe and reliable. The tea can be drunk for a long term, and brings effects of thirst quenching, inflammation eliminating, refreshing, and yin-yang regulating.